425: Strive and Semler Scientific Advance Merger Plans

Strive, Inc. and Semler Scientific, Inc. are progressing with their proposed business combination, as detailed in a recent SEC filing.

Summary

• Strive, Inc. (Strive) and Semler Scientific, Inc. (Semler Scientific) are pursuing a proposed business combination.
• The communication regarding the merger was reposted on X.com by Ben Werkman, Chief Investment Officer of Strive, on December 22, 2025.
• Strive has filed a Registration Statement on Form S-4 with the SEC, which includes an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus has been sent to Semler Scientific stockholders to seek their approval for the proposed transaction.
• The filing contains forward-looking statements concerning the strategic and financial benefits, expected impact on future financial performance, timing of closing, and successful integration of the combined businesses.

Sentiment

Score: 6

Explanation: The filing is a standard legal disclosure for a proposed business combination, emphasizing forward-looking statements and a comprehensive list of associated risks, maintaining a neutral but cautious tone regarding the transaction's completion and outcomes.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are expected to positively impact the combined company's future financial performance.
• The companies aim for successful integration of their businesses post-merger.

Risks

• The merger agreement could be terminated due to unforeseen events, changes, or circumstances.
• The proposed transaction may not close as expected or at all if closing conditions are not met in a timely manner.
• Potential legal proceedings could be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all, potentially due to changes in Bitcoin treasury strategies, general economic conditions, interest/exchange rates, monetary policy, and regulatory enforcement.
• The integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unexpected factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction could cause dilution.
• There is a risk of adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

The outlook includes expectations for strategic and financial benefits from the proposed transaction, its impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the businesses. These are forward-looking statements subject to inherent risks and uncertainties.

Management Comments

• Ben Werkman, Chief Investment Officer of Strive, Inc., reposted the communication on X.com regarding the proposed business combination.

Industry Context

The mention of 'Bitcoin treasury strategies' as a risk factor suggests that the combined entity may be exploring or implementing digital asset strategies, aligning with a growing trend among some companies to incorporate cryptocurrencies into their financial operations or investment portfolios.

Stakeholder Impact

• Shareholders of Semler Scientific are required to approve the proposed transaction.
• Strive shareholders may experience dilution due to the issuance of additional Class A common stock in connection with the merger.
• Customers of both companies may have adverse reactions to the proposed transaction.
• Business and employee relationships could change as a result of the announcement or completion of the proposed transaction.

Next Steps

• Semler Scientific stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and vote on the proposed transaction.
• The proposed transaction is expected to close, subject to conditions being satisfied.
• The combined businesses will undergo integration post-closing.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.

Key Dates

Keywords

Merger, Business Combination, SEC Filing, Strive Inc., Semler Scientific Inc., Form 425, Forward-Looking Statements, Corporate Governance, Bitcoin Treasury Strategies